Principal Financial Group
TRIL

Principal Financial Group’s Trillium Therapeutics Inc. TRIL Stock Holding History

Principal Financial Group’s Portfolio TRIL Stock Details TRIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-10,302
Closed -$181K – 2709
2021
Q3 		$181K Sell
10,302
-1,647
-14% -$19.2K ﹤0.01% 2447
2021
Q2 		$116K Buy
+11,949
New +$112K ﹤0.01% 2520

Other funds holding TRIL

Optiver Holding
Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

Principal Financial Group's TRIL Position: Q4 2021 in Review

Principal Financial Group sold out of Trillium Therapeutics Inc. (TRIL) in Q4 2021, closing a stake of 10,302 shares — an estimated $181K sold.

Principal Financial Group first reported a position in TRIL in Q2 2021 and held it in 2 quarters. The position peaked at $181K in Q3 2021. 2 funds tracked by Wall St. Rank hold TRIL as of Q4 2021.

  • Principal Financial Group reported no remaining Trillium Therapeutics Inc. position as of Q4 2021 after selling out during the quarter.
  • Principal Financial Group sold 10,302 Trillium Therapeutics Inc. shares in Q4 2021, an estimated $181K.
  • Principal Financial Group first reported a position in Trillium Therapeutics Inc. in Q2 2021 and held it in 2 quarters.
  • Principal Financial Group's Trillium Therapeutics Inc. position peaked at $181K in Q3 2021.
  • 2 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2021.

Based on Principal Financial Group's 13F filing for Q4 2021, filed 9 Feb 2022.